SLC2A4 and Insulin resistance: Previous studies have suggested that PI-induced insulin resistance and diabetes are associated with the inhibition of glucose transporter 4 (GLUT4) translocation (3,4) and that lopinavir inhibits the phosphorylation of insulin receptor substrate (IRS) (5).